Be in the know. 20 key reads for Friday…

  1. China Tech Stocks Are Winning Back Investors After Awful Year (bloomberg)
  2. A stock market indicator with one of the best track records has rare good news for investors (marketwatch)
  3. China estimates 250mn people have caught Covid in 20 days (ft)
  4. Supply Chains Upended by Covid Are Back to Normal (wsj)
  5. Inflation Slowed, but Holiday Spending Didn’t Keep Up (barrons)
  6. New Alzheimer’s Drug Could Cost $20,000 a Year: Group (barrons)
  7. Is a 2023 stock-market rebound in store after 2022 selloff? What history says about back-to-back losing years. (marketwatch)
  8. Here’s how U.S. investors can position themselves for the sea change out of Japan, according to Bank of America and Citi (marketwatch)
  9. Fed-favored PCE index shows annualized U.S. inflation rate falling to 5.5% in November (marketwatch)
  10. High U.S. inflation is on the wane, PCE price gauge shows (marketwatch)
  11. Senate Passes $1.65 Trillion Omnibus Bill After Deal on Title 42 Votes (wsj)
  12. Consumer Spending Rose Modestly in November (wsj)
  13. How China Downgraded Covid From ‘Devil’ Virus to a Common Cold (bloomberg)
  14. China Estimates Covid Surge Is Infecting 37 Million People a Day (bloomberg)
  15. UMich Inflation Expectations Tumble To 18-Month Lows (zerohedge)
  16. Tencent chief blasts managers in fiery townhall – sources (reuters)
  17. Equity funds record largest ever weekly outflows -BofA (reuters)
  18. Meta and Alphabet lose dominance over US digital ads market (ft)
  19. SoftBank raises $22bn in moves to sell down Alibaba stake (ft)
  20. BioNTech mRNA Vaccine Approved in Hong Kong, Week in Review (chinalastnight)